Home / MMP-8 / Human Total MMP-8 Quantikine ELISA Kit

Human Total MMP-8 Quantikine ELISA Kit

Catalog #: DMP800
27 Citations 1 Review Datasheet / COA / SDS
Newer Version Available: DMP800B
NEW

Discontinued Product

DMP800 has been discontinued and is replaced by DMP800B.

Human Total MMP-8 ELISA Standard Curve
4 Images
Product Details
Procedure
Citations (27)
FAQs
Reviews (1)
Summary Precision Recovery Linearity Data Examples Product Datasheets Preparation and Storage Background Related Research Areas

Human Total MMP-8 Quantikine ELISA Kit Summary

Assay Type
Solid Phase Sandwich ELISA
Format
96-well strip plate
Assay Length
4.5 hours
Sample Type & Volume Required Per Well
Cell Culture Supernates (10 uL), Serum (10 uL), Heparin Plasma (10 uL), Saliva (10 uL)
Sensitivity
0.06 ng/mL
Assay Range
0.2 - 10 ng/mL (Cell Culture Supernates, Serum, Heparin Plasma, Saliva)
Specificity
Natural and recombinant human MMP-8
Cross-reactivity
< 0.5% cross-reactivity observed with available related molecules.Cross-species reactivity not tested.
Interference
No significant interference observed with available related molecules.

Product Summary

The Quantikine Human Total MMP-8 Immunoassay is a 4.5 hour solid phase ELISA designed to measure total MMP-8 (pro- and active MMP-8) in cell culture supernates, serum, plasma, and saliva. It contains NS0-expressed recombinant human MMP-8 and antibodies raised against the recombinant protein. Natural human MMP-8 showed dose-response curves that were parallel to the standard curves obtained using the recombinant Quantikine kit standards indicating that this kit can be used to determine relative levels of natural human MMP-8.

Precision

Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested on one plate to assess intra-assay precision
Inter-Assay Precision (Precision between assays) Three samples of known concentration were tested in separate assays to assess inter-assay precision

Cell Culture Supernates, Serum, Heparin Plasma, Saliva

Intra-Assay Precision Inter-Assay Precision
Sample 1 2 3 1 2 3
n 20 20 20 40 40 40
Mean (ng/mL) 1.25 3.61 7.24 1.21 3.53 6.85
Standard Deviation 0.065 0.182 0.388 0.073 0.147 0.343
CV% 5.2 5 5.4 6 4.2 5

Recovery

The recovery of MMP-8 spiked to levels throughout the range of the assay in various matrices was evaluated.

Sample Type Average % Recovery Range %
Cell Culture Media (n=8) 95 86-112
Heparin Plasma (n=5) 102 90-114
Serum (n=5) 97 88-105

Linearity

To assess the linearity of the assay, samples containing high concentrations of MMP-8 were serially diluted with Calibrator Diluent to produce samples with values within the dynamic range of the assay.
Human Total MMP-8 ELISA Linearity
Human Total MMP-8 ELISA Linearity

Scientific Data

N/A Human Total MMP-8 ELISA Standard Curve View Larger

Human Total MMP-8 ELISA Standard Curve

N/A Human Total MMP-8 Standard Curve View Larger

Human Total MMP-8 Standard Curve

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Preparation and Storage

Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: MMP-8

The matrix metalloproteinases (MMPs) consist of 24 known human zinc proteases with essential roles in breaking down components of the extracellular matrix (ECM). Additional MMP substrates include cytokines, chemokines, growth factors and binding proteins, cell/cell adhesion molecules, and other proteinases. With a few exceptions, MMPs share common structural motifs including a pro-peptide domain, a catalytic domain, a hinge region, and a hemopexin-like domain. Synthesized as pro-enzymes, most MMPs are secreted before conversion to their active form. MMP activities are modulated on several levels including transcription, pro-enzyme activation, or by their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs). A subset of MMPs are associated with membranes and designated as membrane-type metalloproteinases (MT-MMP).

Long Name:
Matrix Metalloproteinase 8
Entrez Gene IDs:
4317 (Human); 17394 (Mouse); 63849 (Rat)
Alternate Names:
CLG1HNC; Collagenase 2; EC 3.4.24; EC 3.4.24.34; matrix metallopeptidase 8 (neutrophil collagenase); matrix metalloproteinase 8 (neutrophil collagenase); Matrix metalloproteinase-8; MMP8; MMP-8; neutrophil collagenase; PMNL collagenase; PMNL-CL
&#9888; WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Assay Procedure

Refer to the product for complete assay procedure.

Bring all reagents and samples to room temperature before use. It is recommended that all samples, standards, and controls be assayed in duplicate.
  1.   Prepare all reagents, standard dilutions, and samples as directed in the product insert.
  2.   Remove excess microplate strips from the plate frame, return them to the foil pouch containing the desiccant pack, and reseal.
    3. 150 µL Assay Diluent
  3.   Add 150 µL of Assay Diluent to each well.
    4. 50 µL Standard, Control, or Sample
  4.   Add 50 µL of Standard, control, or sample to each well. Cover with a plate sealer, and incubate at room temperature for 2 hours on a horizontal orbital microplate shaker.
  5.   Aspirate each well and wash, repeating the process 3 times for a total of 4 washes.
    6. 200 µL Conjugate
  6.   Add 200 µL of Conjugate to each well. Cover with a new plate sealer, and incubate at room temperature for 2 hours on the shaker.
  7.   Aspirate and wash 4 times.
    8. 200 µL Substrate Solution
  8.   Add 200 µL Substrate Solution to each well. Incubate at room temperature for 30 minutes on the benchtop. PROTECT FROM LIGHT.
    9. 50 µL Stop Solution
  9.   Add 50 µL of Stop Solution to each well. Read at 450 nm within 30 minutes. Set wavelength correction to 540 nm or 570 nm.

Citations for Human Total MMP-8 Quantikine ELISA Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

27 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility
    Authors: S Russo, F Cathomas, HY Lin, K Chan, L Li, RD Cuttoli, L Parise, A Aubry, S Muhareb, F Desland, Y Shimo, A Ramakrishn, M Estill, C Ferrer-Per, E Parise, J Wang, A Sowa, W Janssen, S Costi, A Rahman, N Fernandez, F Swirski, E Nestler, L Shen, M Merad, J Murrough
    Research square, 2023-01-30;0(0):.
    Species: Human
    Sample Types: Serum
  2. Effect of ultrasonic scaling with adjunctive photodynamic therapy in the treatment of gingival inflammation among diabetic patients undergoing fixed orthodontic treatment
    Authors: ML Mannakanda, MA Kamran, SE Udeabor, MS Hameed, M Ajmal, I Alshahrani
    Photodiagnosis and photodynamic therapy, 2021-05-27;0(0):102360.
    Species: Human
    Sample Types: Gingival Crevicular Fluid
  3. The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension
    Authors: Y Yuan, H Naito, K Kitamori, S Hashimoto, T Asano, T Nakajima
    PLoS ONE, 2020-12-14;15(12):e0243846.
    Species: Rat
    Sample Types: Serum
  4. A new rapid bedside test to diagnose and monitor intraamniotic inflammation in preterm PROM using transcervically collected fluid
    Authors: KJ Oh, J Lee, R Romero, HS Park, JS Hong, BH Yoon
    Am. J. Obstet. Gynecol., 2020-02-27;0(0):.
    Species: Human
    Sample Types: Amniotic Fluid
  5. Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls
    Authors: A Kobus, J Bagi?ska, J ?api?ska-A, S ?awicki, A Kierklo
    Biomed Res Int, 2019-10-28;2019(0):7420345.
    Species: Human
    Sample Types: Saliva
  6. Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction
    Authors: H Yogasundar, A Nikhanj, BN Putko, M Boutin, S Jain-Ghai, A Khan, C Auray-Blai, ML West, GY Oudit
    J Am Heart Assoc, 2018-11-06;7(21):e009098.
    Species: Human
    Sample Types: Plasma
  7. MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - First results of a cross-sectional study
    Authors: G Schmalz, I Davarpanah, J Jäger, RF Mausberg, B Krohn-Grim, J Schmidt, R Haak, U Sack, D Ziebolz
    J Microbiol Immunol Infect, 2017-09-04;0(0):.
    Species: Human
    Sample Types: Serum
  8. Relationship between Serum Levels of Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinases-1 and Exercise Test Results in Postmenopausal Women
    Authors: J Mieczkowsk, E Rutkowska, J Mosiewicz, B Mosiewicz
    Dis. Markers, 2016-12-26;2016(0):7169531.
    Species: Human
    Sample Types: Serum
  9. Identification of Gingival Crevicular Fluid Sampling, Analytical Methods, and Oral Biomarkers for the Diagnosis and Monitoring of Periodontal Diseases: A Systematic Review
    Authors: Z Nazar Maje, K Philip, AM Alabsi, S Pushparaja, D Swaminatha
    Dis. Markers, 2016-12-15;2016(0):1804727.
    Species: Human
    Sample Types: Saliva
  10. The effect of type 2 diabetes mellitus and smoking on periodontal parameters and salivary matrix metalloproteinase-8 levels
    Authors: N Gupta, ND Gupta, S Garg, L Goyal, A Gupta, S Khan, S Moin
    J Oral Sci, 2016-01-01;58(1):1-6.
    Species: Human
    Sample Types: Saliva
  11. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.
    Authors: Symeonidis C, Papakonstantinou E, Androudi S, Tsaousis KT, Tsinopoulos I, Brazitikos P, Karakiulakis G, Diza E, Dimitrakos SA
    Cytokine, 2012-05-10;59(1):184-90.
    Species: Human
    Sample Types: Subretinal Fluid
  12. Validation and quality control of ELISAs for the use with human saliva samples.
    Authors: Jaedicke KM, Taylor JJ, Preshaw PM
    J. Immunol. Methods, 2012-01-28;377(1):62-5.
    Species: Human
    Sample Types: Saliva
  13. Early Elevation of Matrix Metalloproteinase-8 and -9 in Pediatric ARDS Is Associated with an Increased Risk of Prolonged Mechanical Ventilation.
    Authors: Kong MY, Li Y, Oster R, Gaggar A, Clancy JP
    PLoS ONE, 2011-08-03;6(8):e22596.
    Species: Human
    Sample Types: Tissue Secretion
  14. Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans.
    Authors: Aronis KN, Diakopoulos KN, Fiorenza CG
    Diabetologia, 2011-06-10;54(9):2358-67.
    Species: Human
    Sample Types: Serum
  15. Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.
    Authors: Jonasson S, Lundberg A, Kalvegren H, Bergstrom I, Szymanowski A, Jonasson L
    PLoS ONE, 2011-04-29;6(4):e19340.
    Species: Human
    Sample Types: Serum
  16. Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy.
    Authors: Symeonidis C, Papakonstantinou E, Androudi S, Rotsos T, Diza E, Brazitikos P, Karakiulakis G, Dimitrakos SA
    Cytokine, 2011-02-25;54(2):212-7.
    Species: Human
    Sample Types: Vitreous Humor
  17. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.
    Authors: Reikvam H, Hatfield KJ, Oyan AM, Kalland KH, Kittang AO, Bruserud O
    Eur. J. Haematol., 2009-11-17;84(3):239-51.
    Species: Human
    Sample Types: Cell Culture Supernates
  18. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation.
    Authors: Roderfeld M, Rath T, Schulz R, Seeger W, Tschuschner A, Graf J, Roeb E
    J. Cyst. Fibros., 2009-07-14;8(5):338-47.
    Species: Human
    Sample Types: Serum
  19. Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer.
    Authors: Agarwal A, Covic L, Sevigny LM, Kaneider NC, Lazarides K, Azabdaftari G, Sharifi S, Kuliopulos A
    Mol. Cancer Ther., 2008-09-01;7(9):2746-57.
    Species: Human
    Sample Types: Ovarian Ascites Fluid
  20. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients.
    Authors: Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, Blalock JE, Clancy JP
    Am. J. Physiol. Lung Cell Mol. Physiol., 2007-03-23;293(1):L96-L104.
    Species: Human
    Sample Types: Sputum
  21. Changes in periodontal and rheumatological conditions after 2 years in patients with juvenile idiopathic arthritis.
    Authors: Miranda LA, Braga F, Fischer RG, Sztajnbok FR, Figueredo CM, Gustafsson A
    J. Periodontol., 2006-10-01;77(10):1695-700.
    Species: Human
    Sample Types:
  22. Aberrant neutrophil reactions in periodontitis.
    Authors: Figueredo CM, Fischer RG, Gustafsson A
    J. Periodontol., 2005-06-01;76(6):951-5.
    Species: Human
    Sample Types:
  23. Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes.
    Authors: Biggio JR, Ramsey PS, Cliver SP, Lyon MD, Goldenberg RL, Wenstrom KD
    Am. J. Obstet. Gynecol., 2005-01-01;192(1):109-13.
    Species: Human
    Sample Types: Amniotic Fluid
  24. Differential modulation of human melanoma cell metalloproteinase expression by alpha2beta1 integrin and CD44 triple-helical ligands derived from type IV collagen.
    Authors: Baronas-Lowell D, Lauer-Fields JL, Borgia JA, Sferrazza GF, Al-Ghoul M, Minond D, Fields GB
    J. Biol. Chem., 2004-08-02;279(42):43503-13.
    Species: Human
    Sample Types: Cell Culture Supernates
  25. Shifts in biochemical markers associated with wound healing in laryngeal secretions following phonotrauma: a preliminary study.
    Authors: Verdolini K, Rosen CA, Branski RC, Hebda PA
    Ann. Otol. Rhinol. Laryngol., 2003-12-01;112(12):1021-5.
    Species: Human
    Sample Types: Tissue Secretion
  26. Effect of tobacco smoking on neutrophil activity following periodontal surgery.
    Authors: Persson L, Bergstrom J, Gustafsson A
    J. Periodontol., 2003-10-01;74(10):1475-82.
    Species: Human
    Sample Types:
  27. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.
    Authors: Marx N, Froehlich J, Siam L, Ittner J, Wierse G, Schmidt A, Scharnagl H, Hombach V, Koenig W
    Arterioscler. Thromb. Vasc. Biol., 2003-02-01;23(2):283-8.
    Species: Human
    Sample Types: Serum

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs

Reviews for Human Total MMP-8 Quantikine ELISA Kit

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human Total MMP-8 Quantikine ELISA Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human Total MMP-8 Quantikine ELISA Kit
By Anonymous on 05/22/2017
Sample Tested: Cell culture supernatant